Recurrent Vesiculonecrotic Lesions on the Lower Extremities in a Patient with Dermatomyositis: A Quiz

Schimpff S, Serpick A, Stoler B, Rumack B, Mellin H, Joseph JM, et al. Varicella-zoster infection in patients with cancer. Ann Intern Med 1972; 76: 241–254.

https://doi.org/10.7326/0003-4819-76-2-241 DOI: https://doi.org/10.7326/0003-4819-76-2-241

Uchiyama E, Yamaguchi R, Anzawa K, Fujii T, Watanabe D, Shimizu A. Vasculitis-like herpes zoster in the course of treatment with tofacitinib in ulcerative colitis: an assessment of local viral distribution by RNA in situ hybridization. J Dermatol 2024; 51: 1248–1251.

https://doi.org/10.1111/1346-8138.17169 DOI: https://doi.org/10.1111/1346-8138.17169

Clark AK, Dhossche J, Korcheva VB, Keller JJ. Herpes zoster presenting as unilateral vasculitis. Dermatol Online J 2018; 24: 10.

https://doi.org/10.5070/D32411042007 DOI: https://doi.org/10.5070/D32411042007

Álvarez-Salafranca M, Garces-Horna V, Garcia-Garcia M, Ara-Martin M. Atypical vasculopathic varicella-zoster infection mimicking cutaneous small-vessel vasculitis. Int J Dermatol 2020; 59: e214–e216.

https://doi.org/10.1111/ijd.14816 DOI: https://doi.org/10.1111/ijd.14816

Zhao R, Nadelman DA, Harms PW, Eshaq M. Disseminated zoster with vasculitis. JAAD Case Rep 2022; 28: 28–30.

https://doi.org/10.1016/j.jdcr.2022.08.002 DOI: https://doi.org/10.1016/j.jdcr.2022.08.002

Lin CF, Hong CT, Lee WH, Wu D, Hu CJ, Chung CC. Disseminated cutaneous herpes zoster and multiple cerebral infarcts in an adult with diabetes mellitus. J Neurovirol 2020; 26: 130–132.

https://doi.org/10.1007/s13365-019-00790-7 DOI: https://doi.org/10.1007/s13365-019-00790-7

Min MS, Alsarheed A, Kassamali B, Mazori DR, Schaefer M, Merola JF, et al. Tofacitinib as treatment for refractory dermatomyositis: a retrospective study from 2 academic medical centers. J Am Acad Dermatol 2022; 86: 423–425.

https://doi.org/10.1016/j.jaad.2021.07.003 DOI: https://doi.org/10.1016/j.jaad.2021.07.003

Almanzar G, Kienle F, Schmalzing M, Maas A, Tony HP, Prelog M. Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritis. Rheumatology (Oxford) 2019; 58: 2051–2060.

https://doi.org/10.1093/rheumatology/kez175 DOI: https://doi.org/10.1093/rheumatology/kez175

Lichtenstein GR, Bressler B, Francisconi C, Vermeire S, Lawendy N, Salese L, et al. Assessment of safety and efficacy of tofacitinib, stratified by age, in patients from the Ulcerative Colitis Clinical Program. Inflamm Bowel Dis 2023; 29: 27–41.

https://doi.org/10.1093/ibd/izac084 DOI: https://doi.org/10.1093/ibd/izac084

Lin QX, Meng HJ, Pang YY, Qu Y. Recurrent herpes zoster in a rheumatoid arthritis patient treated with tofacitinib: a case report and review of the literature. World J Clin Cases 2022; 10: 8703–8708.

https://doi.org/10.12998/wjcc.v10.i24.8703 DOI: https://doi.org/10.12998/wjcc.v10.i24.8703